MR Imaging of Multiple Myeloma in Tumour Mass Measurement at Diagnosis and During Treatment

References

• Bartl R., Frisch B., Fateh-Moghadam A., Kettner G., Jaeger K., Sommerfeld W. Histologic classification and staging of multiple myeloma. A retrospective and prospective study of 674 cases. Am. J. Clin. Pathol. 1987; 87: 342
   PubMed Web of Science ®Google Scholar
• Bataille R., Durie B. G. H., Grenier J. Serum β2-microglobulin and survival duration in multiple myeloma. A simple reliable marker for staging. Br. J. Haematol. 1983; 55: 439
   PubMed Web of Science ®Google Scholar
• Bataille R., Grenier J., Sany J. Beta-2-microglobulin in myeloma. Optimal use for staging, prognosis and treatment. A prospective study of 160 patients. Blood 1984; 63: 468
   PubMed Web of Science ®Google Scholar
• Belch A., Shellwy W., Bersagel D., et al. A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients. Br. J. Cancer 1988; 57: 94
   PubMed Web of Science ®Google Scholar
• Brenning G., Simonsson B., Källander C., Åhre A. Pretreatment serum β2-microglobulin in multiple myeloma. Br. J. Haematol. 1986; 62: 85
   PubMed Web of Science ®Google Scholar
• Committee of The Chronic Leukemia–Myeloma Task Force. Proposed guidelines for protocol studies. II. Plasma cell myeloma. National Cancer Institute. Cell. Chemother. Rep. 1973; 4: 145
   Google Scholar
• Daffner R., Lupetin A., Dash N., Deeb Z., Sefczek R., Scharpio R. MRI in the detection of malignant infiltration of bone marrow. AJR 1986; 146: 353
   PubMed Web of Science ®Google Scholar
• Dimopoulos M. A., Moulopoulos A., Smith T., Delsalle K. B., Alexanian R. Risk of disease progression in asymtomatic multiple myeloma. Am. J. Med. 1993; 94: 57
   PubMed Web of Science ®Google Scholar
• Dixon T. W. Simple proton spectroscopic imaging. Radiology 1984; 153: 189
   PubMed Web of Science ®Google Scholar
• Durie B. G. H., Salmon S. A clinical staging for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842
   PubMed Web of Science ®Google Scholar
• Durie B., Stock-Novack D., Salmon S., et al. Prognostic value of pretreatment serum β2 microglobulin in myeloma. A Southwest Oncology Study Group study. Blood 1990; 75: 823
   PubMed Web of Science ®Google Scholar
• Fruehwald F., Tscholakoff D., Schwaighofer B., et al. Magnetic resonance imaging of the lower vertebral column in patients with multiple myeloma. Invest. Radiol. 1988; 23: 193
   PubMed Web of Science ®Google Scholar
• Gahrton G., Tura S., Ljungman P., , The European Group for Bone Marrow Transplantation), et al. Allogeneic bone marrow transplanation in multiple myeloma. N. Engl. J. Med. 1991; 325: 1267
   PubMed Web of Science ®Google Scholar
• Hayward L. J., Rubens R. D., Carbone P. P., Heuson J. C., Kumaoka S., Sagaloff A. Assessment of response to therapy in advanced breast cancer. Br. J. Cancer 1977; 35: 292
   PubMed Web of Science ®Google Scholar
• Libshitz H., Malthouse S., Cunningham D., MacVicar D., Husband J. Multiple myeloma. Appearance at MR imaging. Radiology 1992; 182: 833
   PubMed Web of Science ®Google Scholar
• von Linden A., Gückel C., Widder R., Jungehülsing M., Diehl V., Schicha H. Kernspinntomographie beim Plasmozytom. RÖFO 1992; 156: 83
   PubMedGoogle Scholar
• Ludwig H., Scholakoff D., Neuhold A., Frühwald F., Rasoul S., Fritz E. Magnetic resonance imaging of the spine in multiple myeloma. Lancet 1987; ii: 364
   Google Scholar
• Mandelli F., Avvisati G., Amadori S., et al. Maintenance treatment with recombinant interferon α-2b in patients with multiple myeloma responding to conventional induction chemotherapy. N. Engl. J. Med. 1990; 322: 1430
   PubMed Web of Science ®Google Scholar
• Moulopoulos L. A., Varma D. G. K., Dimopoulos M. A., et al. Multiple myeloma. Spinal MR imaging in patients with untreated newly diagnosed disease. Radiology 1992; 185: 833
   PubMed Web of Science ®Google Scholar
• Nyman R., Rehn S., Glimelius B., et al. Magnetic resonance imaging in diffuse malignant bone marrow diseases. Acta. Radiol. 1987; 28: 199
   PubMed Web of Science ®Google Scholar
• Olson D., Shields A., Scheurich J., Porter B., Moss A. Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anaemia, and lymphoma. Invest. Radiol. 1986; 21: 540
   PubMed Web of Science ®Google Scholar
• Rahmouni A., Divine M., Mathieu D., et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR 1993; 160: 1053
   PubMed Web of Science ®Google Scholar
• Sepponen R. E., Sipponen J. P., Tanttu J. I. J. A method for chemical shift imaging. Demonstration of bone marrow involvement with proton chemical shift imaging. J. Comput. Assist. Tomogr. 1984; 8: 585
   PubMed Web of Science ®Google Scholar